Form 4: Medtronic Executive Michael Marinaro Reports Stock Transactions

EVP & President, Surgical OU, Michael Marinaro, reports acquisition and disposal of Medtronic plc ordinary shares related to performance share unit settlement and tax withholding.

Summary

• Michael Marinaro, an Executive Vice President & President, Surgical OU at Medtronic plc, reported transactions involving Medtronic ordinary shares on August 2, 2024.
• These transactions include the acquisition of 1,670 shares upon the settlement of performance-vesting restricted stock units.
• Marinaro also disposed of 563 shares and 847 shares to cover tax obligations related to the settlement and vesting of restricted stock units.
• Following these transactions, Marinaro directly owns 42,391 ordinary shares.
• He also holds 1,670 performance share units, each representing a contingent right to receive one share of Medtronic common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations.

Positives

• The acquisition of shares through performance-vesting restricted stock units suggests Marinaro met certain performance criteria.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders as they are related to executive compensation and tax obligations.

Key Dates